Man Group’s Royalty Pharma RPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $513K | Sell |
14,238
-64,673
| -82% | -$2.33M | ﹤0.01% | 1605 |
|
|
2025
Q1 | $2.46M | Sell |
78,911
-736,516
| -90% | -$22.9M | 0.01% | 1115 |
|
|
2024
Q4 | $20.8M | Buy |
815,427
+433,245
| +113% | +$11.1M | 0.05% | 359 |
|
|
2024
Q3 | $10.8M | Sell |
382,182
-628,286
| -62% | -$17.8M | 0.03% | 637 |
|
|
2024
Q2 | $26.6M | Buy |
1,010,468
+813,343
| +413% | +$21.4M | 0.07% | 332 |
|
|
2024
Q1 | $5.99M | Sell |
197,125
-2,382,027
| -92% | -$72.3M | 0.02% | 869 |
|
|
2023
Q4 | $72.4M | Buy |
+2,579,152
| New | +$72.4M | 0.2% | 106 |
|
|
2023
Q3 | – | Sell |
-578,053
| Closed | -$17.8M | – | 249 |
|
|
2023
Q2 | $17.8M | Buy |
+578,053
| New | +$17.8M | 0.05% | 419 |
|
|
2023
Q1 | – | Sell |
-321,558
| Closed | -$12.7M | – | 516 |
|
|
2022
Q4 | $12.7M | Buy |
321,558
+18,465
| +6% | +$730K | 0.05% | 477 |
|
|
2022
Q3 | $12.2M | Buy |
+303,093
| New | +$12.2M | 0.06% | 410 |
|
|
2022
Q2 | – | Sell |
-176,115
| Closed | -$6.86M | – | 365 |
|
|
2022
Q1 | $6.86M | Buy |
176,115
+135,259
| +331% | +$5.27M | 0.02% | 756 |
|
|
2021
Q4 | $1.63M | Buy |
+40,856
| New | +$1.63M | 0.01% | 1216 |
|
|
2021
Q2 | – | Sell |
-24,232
| Closed | -$1.06M | – | 1996 |
|
|
2021
Q1 | $1.06M | Buy |
+24,232
| New | +$1.06M | ﹤0.01% | 1278 |
|
|
2020
Q4 | – | Sell |
-37,062
| Closed | -$1.56M | – | 1915 |
|
|
2020
Q3 | $1.56M | Buy |
+37,062
| New | +$1.56M | 0.01% | 1263 |
|